BlueCrest Capital Management’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-563,480
Closed -$1.23M 706
2020
Q4
$1.23M Sell
563,480
-807,591
-59% -$1.6M 0.03% 279
2020
Q3
$2.41M Sell
1,371,071
-589,820
-30% -$1.01M 0.09% 164
2020
Q2
$2.67M Sell
1,960,891
-128,231
-6% -$160K 0.14% 111
2020
Q1
$1.97M Buy
2,089,122
+225,969
+12% +$278K 0.14% 87
2019
Q4
$2.85M Buy
+1,863,153
New +$2.63M 0.18% 90

Other funds holding NFH.WS

BlueCrest Capital Management's NFH.WS Position: Q1 2021 in Review

BlueCrest Capital Management sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2021, closing a stake of 563,480 shares — an estimated $1.23M sold.

BlueCrest Capital Management first reported a position in NFH.WS in Q4 2019 and held it in 5 quarters. The position peaked at $2.85M in Q4 2019. 11 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2021.

  • BlueCrest Capital Management reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 563,480 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2021, an estimated $1.23M.
  • BlueCrest Capital Management first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 5 quarters.
  • BlueCrest Capital Management's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $2.85M in Q4 2019.
  • 11 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2021.

Based on BlueCrest Capital Management's 13F filing for Q1 2021, filed 17 May 2021.